Similarly, in a murine atopic dermatitis model, epicutanous application of ovalbumin in conjunction with CpG was effective for treatment by promoting a strong Th1-mediated immune response leading to a decrease in antigen-specific IgE and increase in IgG2a antibodies [45]. This evidence concerns the gene IGHE and atopic eczema.